Ocugen, inc. (HSGX)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash flows from operating activities
Net loss

-17,873

-20,242

-38,581

-12,260

-9,699

-18,219

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-15,371

-16,208

-33,620

-32,383

-31,978

-32,024

-22,755

-26,651

-27,320

-22,793

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense

0

-

-

-

0

-

-

-

1,312

1,534

1,584

1,600

1,637

1,673

1,699

1,708

1,673

1,614

1,426

1,181

944

726

0

0

0

Non-cash interest expense

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash lease expense

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of discount of investments

-

-

-

-

-

-

-

-

-

-54

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent and lease incentive

-

-

-

-

-

-

-

-541

-444

543

540

538

534

533

531

527

382

322

979

736

688

541

0

0

0

Stock-based compensation

-

-

-

-

-

-

-

1,519

1,484

1,573

1,701

1,765

1,729

1,548

1,454

1,383

1,304

1,228

1,045

851

706

547

0

0

0

Change in fair value of warrant liability

-

-

-

-

-

-

-

6,330

9,966

1,482

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash consulting expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Change in fair value of derivative liability

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,007

0

0

0

Stock-based compensation expense

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38

0

0

0

Changes in assets and liabilities:
Prepaid expenses and other assets

829

1,007

126

-871

-511

201

326

577

563

21

57

-46

-171

-148

-164

-547

-363

-475

-377

471

502

226

0

0

0

Accounts payable and accrued expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease obligations

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets and accrued lease obligations, net

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

552

-562

-849

-838

-150

175

-435

-63

-436

-1,336

-2,844

-3,106

-464

173

2,026

0

0

0

Accounts payable due to Intrexon Corporation

-

-

-

-

-

-

-

-

-

-360

-135

-269

-260

131

-136

137

16

211

0

0

0

-

-

-

-

Accrued expenses due to Intrexon Corporation

-

-

-

-

-

-

-

-

-

-

-

-

-

1,494

484

847

1,579

1,539

0

0

0

-

-

-

-

Accrued expenses

-

-

-

-

-

-

-

156

18

524

35

120

13

653

1,353

622

-591

-232

-1,491

-1,017

782

648

0

0

0

Deferred revenue

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-18,912

-16,893

-10,935

-21,252

-17,583

-11,630

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from investing activities
Net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-25,240

-25,736

-26,840

-28,263

-29,186

-30,034

-27,715

-23,628

-21,608

-17,938

0

0

0

Purchase of property and equipment

0

-

-

-

-1,167

77

221

2,935

1,494

276

135

81

325

320

448

943

1,066

1,949

3,562

4,448

4,116

3,321

0

0

0

Proceeds from maturities of marketable securities

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of marketable securities

-

-

-

-

-

-

-

-

-

8,004

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-2,398

-2,356

-2,336

1,866

267

-77

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from financing activities
Payment of equity issuance costs

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from stock subscription

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

4,738

0

0

0

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-8,331

-320

-448

-943

-1,066

-1,949

-3,562

-4,448

-4,116

-3,321

0

0

0

Repayments of Debt

-

-

-

-

-

-

-

470

570

583

583

583

583

583

583

583

539

406

0

0

0

-

-

-

-

Financing lease principal payments

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of debt issuance costs

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of debt

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs associated with Initial Public Offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,488

0

0

0

Proceeds from exercise of stock options

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

24,195

25,066

26,089

278

3,048

7,184

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Effect of changes in exchange rate on cash

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

27,048

27,049

27,092

-557

-499

4,371

66,209

65,989

76,012

71,052

0

0

0

Net decrease in cash, cash equivalents and restricted cash

2,884

5,816

12,817

-19,106

-14,268

-4,522

-7,384

-1,790

-867

-24,827

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

993

-196

-29,763

-30,751

-27,612

34,932

37,913

50,288

49,793

0

0

0

Purchases of property and equipment in accounts payable and accrued expenses

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Public offering costs in accounts payable

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Right-of-use asset related to operating leases (Note 8)

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-